![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:7527R Celsis International PLC 07 April 2008 For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: CELSIS INTERNATIONAL PLC 2. Reason for notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (YES) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: (NO ) An event changing the breakdown of voting rights: (NO ) Other (please specify) : ( ) 3. Full name of person(s) subject to notification obligation: RIVER & MERCANTILE ASSET MANAGEMENT LLP 4. Full name of shareholder(s) (if different from 3) : 5. Date of transaction (and date on which the threshold is crossed or reached if different): 04 APRIL 2008 6. Date on which issuer notified: 07 APRIL 2008 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified Details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible use the Triggering transaction ISIN CODE Number of shares Number of voting Rights GB000BOCDSF69 1,088,910 1,088,910 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible use ISIN CODE Direct Indirect Direct Indirect 1,145,910 1,145,910 NIL 5.1% 0% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration date Exercise/conversion No. of voting % of voting financial period/date rights that may rights instrument be acquired (if the instrument exercised/ converted) Total (A+B) Number of voting rights % of voting rights 1,145,910 5.1% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: ALEXANDRA PARRISH 15. Contact telephone number: +33(0)20 7601 6267 For notes on how to complete form TR-1 please see the FSA website. This information is provided by RNS The company news service from the London Stock Exchange END HOLUBOARWRRSRAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions